Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain.

Peterson, Cristina D; Kitto, Kelley F; Verma, Harsha; Pflepsen, Kelsey; Delpire, Eric; Wilcox, George L; Fairbanks, Carolyn A

Peterson, Cristina D; Kitto, Kelley F; Verma, Harsha; Pflepsen, Kelsey; Delpire, Eric; Wilcox, George L; Fairbanks, Carolyn A.

Afiliación

Peterson CD; Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.
Kitto KF; Graduate Program in Experimental and Clinical Pharmacology, University of Minnesota, University of Minnesota, Minneapolis, MN, USA.
Verma H; Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.
Pflepsen K; Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.
Delpire E; Department of Pharmaceutics, University of Minnesota, University of Minnesota, Minneapolis, MN, USA.
Wilcox GL; Department of Anesthesiology, Vanderbilt School of Medicine, Nashville, TN, USA.
Fairbanks CA; Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.

Mol Pain ; 17: 17448069211029171, 2021.

Article en En | MEDLINE | ID: mdl-34210178

Asunto(s)

Agmatina; Neuralgia; Agmatina/farmacología; Agmatina/uso terapéutico; Animales; Maleato de Dizocilpina/farmacología; Ratones; Neuralgia/tratamiento farmacológico; Receptores de N-Metil-D-Aspartato; Médula Espinal

Palabras clave

Agmatine; GluN2B; NMDA; chronic pain; ifenprodil; neuropathic pain

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Agmatina / Neuralgia Límite: Animals Idioma: En Revista: Mol Pain Asunto de la revista: BIOLOGIA MOLECULAR / NEUROLOGIA / PSICOFISIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google